Matt Posard

Matt Posard is the current Director at Talis Biomedical. Prior to this, they were with Deepcell, Inc., Stemson Therapeutics, Nautilus Biotechnology, and Fabric Genomics. Matt has also served on the board of directors for Talis Biomedical Corporation and DermTech. Posard started their career at EXPLORE DNA before moving to Halozyme Therapeutics, Inc. and then Illumina. At Illumina, they held various roles including Sales Analyst, Manager of Customer Service, Manager of Market Research, R&D Project Manager, and Strategic Marketing.

Matt Posard has a BA in Management Science from UC San Diego and a diploma from Agoura Hills High School. Matt also has certification from the Corporate Governance Program in UCLA Anderson School of Busienss (Corporate Governance Program) and certification from UCLA (NACD compliant) in Certified Director, UCLA Anderson School of Management.